Pulsed Dye Laser-mediated Photodynamic Therapy is Less Effective than Conventional Photodynamic Therapy for Actinic Field Cancerization: A Randomized Half-side Comparative Study

Authors

  • Vivian Lindholm Department of Dermatology and Allergology, Skin and Allergy Hospital, Helsinki University Hospital, FIN-00250 Helsinki, Finland
  • Sari Pitkänen
  • Marika Schröder
  • Sonja Hahtola
  • Helka Sahi
  • Heini Halme
  • Kirsi Isoherranen

DOI:

https://doi.org/10.2340/00015555-3754

Keywords:

actinic keratosis, photochemotherapy, lasers, dye

Abstract

Previous research presents pulsed dye laser-mediated photodynamic therapy as a promising alternative to conventional red-light photodynamic therapy. In this study, 60 patients with 2 or more actinic keratoses randomly received either of these treatments on each side of the head. A physician blinded to the treatment evaluated treatment response at 6 months for each lesion, as completely, partially or not healed. Significantly lower complete clearance rates (10.3% vs 44.9%) and lesion-specific complete clearance rates were found for pulsed dye laser-mediated photodynamic therapy (47.9%) vs conventional red-light photodynamic therapy (73.4%). Significantly lower pain scores were found for pulsed dye laser-mediated photodynamic therapy, with a mean numerical rating of 2.3, compared with 4.1 for conventional red-light photodynamic therapy. The study population had a mean of 7.9 lesions, and 78% of patients had been treat­ed previously for actinic keratoses on the treatment area. To conclude, in a population with severe sun dam­age, pulsed dye laser-mediated photodynamic therapy seems less effective than conventional red-light photo­dynamic therapy. Pulsed dye laser-mediated photodynamic therapy may still be a treatment option for patients who are not compliant with conventional red-light photodynamic therapy.

Downloads

Download data is not yet available.

References

Werner RN, Jacobs A, Rosumeck S, Erdmann R, Sporbeck B, Nast A. Methods and results report - evidence and consensus-based (S3) guidelines for the treatment of actinic keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum. J Eur Acad Dermatol Venereol 2015; 29: 1-66.

DOI: https://doi.org/10.1111/jdv.13179

Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23-24.

DOI: https://doi.org/10.1067/mjd.2000.103339

Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994; 131: 455-464.

DOI: https://doi.org/10.1111/j.1365-2133.1994.tb08544.x

Fleming P, Zhou S, Bobotsis R, Lynde C. Comparison of the treatment guidelines for aktinic keratosis: a critical appraisal and review. J Cutan Med Surg 2017; 21: 408-417.

DOI: https://doi.org/10.1177/1203475417708166

Gupta A RJ. Photodynamic therapy and topical aminolevulinic acid: an overview. Am J Clin Derm 2003; 4: 699-708.

DOI: https://doi.org/10.2165/00128071-200304100-00004

Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 2: emerging indications - field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol 2013; 27: 672-679.

DOI: https://doi.org/10.1111/jdv.12026

Braathen LR, Morton CA, Basset-Seguin N, Bissonnette R, Gerritsen MJP, Gilaberte Y, et al. Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 1063-1066.

DOI: https://doi.org/10.1111/j.1468-3083.2011.04432.x

Karrer S, Bäumler W, Abels C, Hohenleutner U, Landthaler M, Szeimies R. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999; 25: 51-59.

DOI: https://doi.org/10.1002/(SICI)1096-9101(1999)25:1<51::AID-LSM7>3.0.CO;2-Y

Kessels, Janneke PHM, Nelemans PJ, Mosterd K, Kelleners-Smeets NWJ, Krekels GAM, et al. Laser-mediated photodynamic therapy: an alternative treatment for actinic keratosis? Acta Derm Venereol 2016; 96: 351-354.

DOI: https://doi.org/10.2340/00015555-2278

Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. JAMA Dermatol 2003; 139: 1313-1320.

DOI: https://doi.org/10.1001/archderm.139.10.1313

Kim BS, Kim JY, Song CH, Kim HY, Lee WJ, Lee S, et al. Light-emitting diode laser versus pulsed dye laser-assisted photodynamic therapy in the treatment of actinic keratosis and Bowen's disease. Dermatol Surg 2012; 38: 151-153.

DOI: https://doi.org/10.1111/j.1524-4725.2011.02240.x

Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.

DOI: https://doi.org/10.1001/archderm.1988.01670060015008

Olsen EA, Abernethy L, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-743.

DOI: https://doi.org/10.1016/0190-9622(91)70113-G

Ruohoalho T, Pitkänen S. [Pulsed dye laser-mediated photodynamic therapy of superficial skin cancers and their precursors]. Licentiate thesis at the University of Helsinki, 2007 [in Finnish].

Galderma. Product leaflet. Actilite CL 128 Description. (accessed 14 December 2020). Uppsala: Galderma. Available from: https://www.galderma.com/se/sites/g/files/jcdfhc271/files/inline-files/Produktblad_Aktilite_DK-NO-eng-2018_0.pdf.

Stockfleth E. The importance of treating the field in actinic keratosis. J Eur Acad Dermatol Venereol 2017; 31: 8-11.

DOI: https://doi.org/10.1111/jdv.14092

Published

2021-02-19

How to Cite

Lindholm, V., Pitkänen, S., Schröder, M., Hahtola, S., Sahi, H., Halme, H., & Isoherranen, K. (2021). Pulsed Dye Laser-mediated Photodynamic Therapy is Less Effective than Conventional Photodynamic Therapy for Actinic Field Cancerization: A Randomized Half-side Comparative Study. Acta Dermato-Venereologica, 101(2), adv00404. https://doi.org/10.2340/00015555-3754